Clinical Trials Directory

Trials / Completed

CompletedNCT01832662

Coffee Polyphenols Antioxidants

Coffee Antioxidant Efficacy in Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

Coffee is one of the most widely consumed beverages. It contains polyphenols (chlorogenic acids) and bioavailability of these bioactive compounds is now somewhat well understood. In addition, chlorogenic acids are known to be antioxidants in the cup, but reliable evidence remains to be observed in vivo. The objective of this trial is to understand if regular (10d) coffee intake may be beneficial on biomarkers of oxidative damage measured in urine and plasma. A secondary objective is to understand if polyphenols isolated from coffee may be as beneficial as the whole beverage in reducing oxidative stress compared to placebo

Detailed description

This is an interventional study with a crossover randomized placebo-controlled double-blind design to assess the effect of regular consumption of coffee on oxidative stress compared to placebo.

Conditions

Interventions

TypeNameDescription
OTHERcoffeecoffee, placebo enriched with polyphenols and placebo with caffeine
OTHERcoffee polyphenols mixed with placebocoffee polyphenols mixed with placebo
OTHERmaltodextrin enriched with caffeinemaltodextrin enriched with caffeine

Timeline

Start date
2011-03-01
Primary completion
2012-04-01
Completion
2013-06-01
First posted
2013-04-16
Last updated
2014-04-21

Source: ClinicalTrials.gov record NCT01832662. Inclusion in this directory is not an endorsement.